You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Dipyridamole

Showing 1 - 25 of 164
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID, Corona Virus Infection, Covid-19 Trial in Ann Arbor (Dipyridamole 100 Milligram(mg), Placebo oral tablet)

Completed
Has Results
  • COVID
  • +3 more
  • Dipyridamole 100 Milligram(mg)
  • Placebo oral tablet
  • Ann Arbor, Michigan
    University of Michigan
Mar 18, 2022

COVID-19 Trial in India (Brequinar Sodium, Dipyridamole 75 MG, Placebo)

Terminated
  • COVID-19
  • Brequinar Sodium
  • +2 more
  • Srikakulam, Andhra Pradesh, India
  • +6 more
Jun 16, 2022

Acute Ischemic Stroke, Thrombocytopenia Trial (aspirin, clopidogrel, cilostazol, and dipyridamole)

Not yet recruiting
  • Acute Ischemic Stroke
  • Thrombocytopenia
  • aspirin, clopidogrel, cilostazol, and dipyridamole
  • (no location specified)
Sep 21, 2023

COVID-19 Pneumonia, Vascular Complications Trial in Farmington (Dipyridamole)

Recruiting
  • COVID-19 Pneumonia
  • Vascular Complications
  • Dipyridamole
  • Farmington, Connecticut
    UConn Health
Sep 28, 2021

Cirrhosis, Splenectomy, Venous Thrombosis Trial in Yangzhou (Apixaban 2.5 MG, Dipyridamole 25Mg Tab, subcutaneous Low Molecular

Recruiting
  • Cirrhosis
  • +3 more
  • Apixaban 2.5 MG
  • +2 more
  • Yangzhou, Jiangsu, China
    Clinical Medical College, Yangzhou University
Apr 30, 2022

Systemic Lupus Erythematosus Trial in Oklahoma City (extended release dipyridamole 200mg/aspirin 25mg, 81mg aspirin)

Terminated
Has Results
  • Systemic Lupus Erythematosus
  • extended release dipyridamole 200mg/aspirin 25mg
  • 81mg aspirin
  • Oklahoma City, Oklahoma
    Oklahoma Medical Research Foundation
Nov 3, 2020

Cirrhosis, Splenectomy; Status, Venous Thrombosis Trial in Yangzhou (Apixaban, Warfarin, Aspirin)

Recruiting
  • Cirrhosis
  • +3 more
  • Yangzhou, Jiangsu, China
    Clinical Medical College of Yangzhou University
Mar 19, 2022

Takotsubo Syndrome Trial in Gothenburg, Stockholm, Umeå (Adenosine, Dipyridamole 200 mg, Apixaban 5 mg Oral Tablet)

Recruiting
  • Takotsubo Syndrome
  • Gothenburg, Sweden
  • +3 more
Jan 17, 2022

IgA Nephropathy, Proteinuria in Nephrotic Range, Immunosuppressive Treatment Trial in Beijing (Corticosteroid, Cyclophosphamide,

Recruiting
  • IgA Nephropathy
  • +2 more
  • Beijing, China
    Peking University First Hospital
Apr 21, 2022

Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder Trial in Baltimore (Dipyridamole, Olanzapine)

Completed
Has Results
  • Schizophrenia
  • +2 more
  • Dipyridamole
  • Olanzapine
  • Baltimore, Maryland
    Maryland Psychiatric Research Center
Oct 31, 2019

Stroke, Transient Ischemic Attack Trial in Philadelphia, Copenhagen (Septal Occluder Device, Antiplatelet Medical Therapy)

Completed
Has Results
  • Stroke
  • Transient Ischemic Attack
  • Septal Occluder Device
  • Antiplatelet Medical Therapy
  • Philadelphia, Pennsylvania
  • +1 more
Oct 23, 2020

Sonazoid in Myocardial Perfusion Imaging

Not yet recruiting
  • Diagnostic Imaging
  • Myocardial Ischemia
  • Contrast Stress Echocardiography
  • Harrow, Middx, United Kingdom
    London North West University Healthcare NHS Trust
Nov 24, 2022

HIV Infection Trial in Pittsburgh (Dipyridamole, Placebo, then Dipyridamole)

Completed
Has Results
  • HIV Infection
  • Dipyridamole
  • Placebo, then Dipyridamole
  • Pittsburgh, Pennsylvania
    Pitt Treatment Evaluation Unit / University of Pittsburgh
Mar 20, 2019

Ischemic Stroke, Transient Ischemic Attack Trial in Singapore (Genetic testing)

Not yet recruiting
  • Ischemic Stroke
  • Transient Ischemic Attack
  • Genetic testing
  • Singapore, Singapore
    Singapore General Hospital
Mar 9, 2023

Coronary Flow Reserve and BH4 Levels in High CV Risk

Completed
  • Hypertension,Essential
  • Echo stress dipyridamole
  • Bergamo, Italy
  • +1 more
Jul 11, 2019

Cardiovascular Disease Trial in Palo Alto (Exercise Therapy)

Completed
Has Results
  • Cardiovascular Disease
  • Exercise Therapy
  • Palo Alto, California
    VA Palo Alto Health Care System, Palo Alto, CA
Aug 24, 2021

Purpura, Schoenlein-Henoch Trial in Changchun (IL-2)

Completed
  • Purpura, Schoenlein-Henoch
  • Changchun, Changchun/JiLin, China
    Sirui Yang
Aug 16, 2022

HCM - Hypertrophic Non-Obstructive Cardiomyopathy Trial in Milan (Ranolazine PR (prolonged-release) 500 mg 1 tablet bis in die

Completed
  • HCM - Hypertrophic Non-Obstructive Cardiomyopathy
  • Ranolazine PR (prolonged-release) 500 mg 1 tablet bis in die and 750 mg 1 tablet bis in die
  • Milan, Italy
    IRCCS Ospedale San Raffaele
Dec 9, 2020

Ischemic Heart Disease Trial in Ottawa (Rb-82 Radioisotope)

Not yet recruiting
  • Ischemic Heart Disease
  • Rb-82 Radioisotope
  • Ottawa, Ontario, Canada
    University of Ottawa Heart Institute
May 18, 2022

SPECT Myocardial Blood Flow Quantitation for Detection of

Completed
  • Coronary Artery Disease
    • Beijing, China
    • +3 more
    Jan 19, 2022

    Cirrhosis, Hypertension, Splenectomy Trial in Yangzhou (laparoscopic splenectomy and azygoportal disconnection with

    Completed
    • Cirrhosis
    • +3 more
    • laparoscopic splenectomy and azygoportal disconnection with intraoperative endoscopic variceal ligation
    • Yangzhou, Jiangsu, China
      Clinical Medical College, Yangzhou University
    Mar 18, 2022

    International REgistry of COnservative or Radical Treatment of

    Recruiting
    • Kidney Cancer
    • Partial Nephrectomy (PN)
    • +3 more
    • Los Angeles, California
    • +36 more
    May 2, 2022

    Dipyridamole Induced Ischemia and Biomarkers

    Completed
    • Ischemic Heart Disease
    • Ischemic Attack
    • myocardial perfusion scintigraphy
    • Pécs, Baranya, Hungary
      University of Pecs
    Sep 27, 2018

    Cirrhosis, Hypertension, Splenectomy Trial in Yangzhou (vagus nerve-guided group)

    Recruiting
    • Cirrhosis
    • +3 more
    • vagus nerve-guided group
    • Yangzhou, Jiangsu, China
      Clinical Medical College, Yangzhou University
    May 1, 2022

    Cirrhosis, Hypertension, Status;Splenectomy Trial in Yangzhou (Warfarin, Dipyridamole, Aspirin)

    Completed
    • Cirrhosis
    • +3 more
    • Yangzhou, Jiangsu, China
      Clinical Medical College of Yangzhou University
    Mar 28, 2019